BIOLINE RX earnings per share and revenue

BLRX earnings per share for the last quarter are -0.05 ILS whereas the estimation was -0.05 ILS which accounts for 13.64% surprise. Company revenue for the same period amounts to 17.43 M ILS despite the estimated figure of 544.64 k ILS. Estimated earnings per share for the next quarter are -0.07 ILS, and revenue is expected to reach 1.26 M ILS. Also watch annual changes over time to get a bigger picture of BLRX earnings per share and revenue dynamics.